TY - JOUR
T1 - The MECP2 variant c.925C>T (p.Arg309Trp) causes intellectual disability in both males and females without classic features of Rett syndrome
AU - Schönewolf-Greulich, Bitten
AU - Tejada, Maria-Isabel
AU - Stephens, K
AU - Hadzsiev, K
AU - Gauthier, J
AU - Brøndum-Nielsen, Karen
AU - Pfundt, R
AU - Ravn, Kirstine Johanne Theresia
AU - Maortua, H
AU - Gener, B
AU - Martínez-Bouzas, C
AU - Piton, A
AU - Rouleau, G
AU - Clayton-Smith, J
AU - Kleefstra, T
AU - Bisgaard, Anne-Marie
AU - Tümer, Zeynep
N1 - © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Missense MECP2 variants can have various phenotypic effects ranging from a normal phenotype to typical Rett syndrome (RTT). In females, the phenotype can also be influenced by the X-inactivation pattern. In this study, we present detailed clinical descriptions of six patients with a rare base-pair substitution affecting Arg309 at the C-terminal end of the transcriptional repression domain (TRD). All patients have intellectual disability and present with some RTT features, but they do not fulfill the clinical criteria for typical or atypical RTT. Most of the patients also have mild facial dysmorphism. Intriguingly, the mother of an affected male patient is an asymptomatic carrier of this variant. It is therefore likely that the p.(Arg309Trp) variation does not necessarily lead to male lethality, and it results in a wide range of clinical features in females, probably influenced by different X-inactivation patterns in target tissues.
AB - Missense MECP2 variants can have various phenotypic effects ranging from a normal phenotype to typical Rett syndrome (RTT). In females, the phenotype can also be influenced by the X-inactivation pattern. In this study, we present detailed clinical descriptions of six patients with a rare base-pair substitution affecting Arg309 at the C-terminal end of the transcriptional repression domain (TRD). All patients have intellectual disability and present with some RTT features, but they do not fulfill the clinical criteria for typical or atypical RTT. Most of the patients also have mild facial dysmorphism. Intriguingly, the mother of an affected male patient is an asymptomatic carrier of this variant. It is therefore likely that the p.(Arg309Trp) variation does not necessarily lead to male lethality, and it results in a wide range of clinical features in females, probably influenced by different X-inactivation patterns in target tissues.
KW - Journal Article
U2 - 10.1111/cge.12769
DO - 10.1111/cge.12769
M3 - Journal article
C2 - 26936630
SN - 0009-9163
VL - 89
SP - 733
EP - 738
JO - Clinical Genetics
JF - Clinical Genetics
IS - 6
ER -